CXL Improved Morphological, Functional Parameters in Select Age Groups

Corneal collagen cross-linking (CXL) stabilized the progression of ectatic disease 4 years postoperatively in all age groups and improved the functional and morphological parameters in select groups, with the best results in patients between 18 and 39 years of age, according to a study in emOphthalmology/em.sup1/sup ...

Full Story →